Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Knight

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Cell Cycle (Georgetown, Tex.)|April 18, 2008
p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1Surinder M Soond, Sean P Barry, Gerry Melino, et al.
Cell Cycle (Georgetown, Tex.)|December 14, 2017
Integrin-β4 is a novel transcriptional target of TAp73Ningxia Xie, Polina Vikhreva, Margherita Annicchiarico-Petruzzelli, et al.
Biochemical and Biophysical Research Communications|March 9, 2002
Osmotic resistance of high-density erythrocytes in transglutaminase 2-deficient miceFrancesca Bernassola, Giovanna Boumis, Marco Corazzari, et al.
Cell Cycle (Georgetown, Tex.)|November 13, 2008
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitisSergio Bernardini, Paolo Gravina, Nicoletta Croce, et al.
The Journal of Biological Chemistry|April 1, 2018
ERK and the F-box protein β TRCP target STAT1 for degradationSurinder M Soond, Paul A Townsend, Sean P Barry, et al.
Cell Cycle (Georgetown, Tex.)|June 26, 2020
P73 C-terminus is dispensable for multiciliogenesisNiall Buckley, Emanuele Panatta, Nobuhiro Morone, et al.
International Journal of Experimental Pathology|September 1, 2010
STAT3 modulates the DNA damage response pathwaySeán P Barry, Paul A Townsend, Richard A Knight, et al.
Biochemical and Biophysical Research Communications|October 28, 2010
p73 regulates maintenance of neural stem cellMassimiliano Agostini, Paola Tucci, Hailan Chen, et al.
Mini Reviews in Medicinal Chemistry|May 2, 2015
Perspective on multi-target antiplatelet therapies: high content phenotypic screening as an unbiased source of novel polypharmacological strategiesVivien Landré, Ivano Amelio, Nick A Barlev, et al.
The Journal of Biological Chemistry|April 2, 2008
ERK and the F-box protein betaTRCP target STAT1 for degradationSurinder M Soond, Paul A Townsend, Sean P Barry, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Cell Cycle (Georgetown, Tex.)|April 18, 2008
p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1Surinder M Soond, Sean P Barry, Gerry Melino, et al.
Cell Cycle (Georgetown, Tex.)|December 14, 2017
Integrin-β4 is a novel transcriptional target of TAp73Ningxia Xie, Polina Vikhreva, Margherita Annicchiarico-Petruzzelli, et al.
Biochemical and Biophysical Research Communications|March 9, 2002
Osmotic resistance of high-density erythrocytes in transglutaminase 2-deficient miceFrancesca Bernassola, Giovanna Boumis, Marco Corazzari, et al.
Cell Cycle (Georgetown, Tex.)|November 13, 2008
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitisSergio Bernardini, Paolo Gravina, Nicoletta Croce, et al.
The Journal of Biological Chemistry|April 1, 2018
ERK and the F-box protein β TRCP target STAT1 for degradationSurinder M Soond, Paul A Townsend, Sean P Barry, et al.
Cell Cycle (Georgetown, Tex.)|June 26, 2020
P73 C-terminus is dispensable for multiciliogenesisNiall Buckley, Emanuele Panatta, Nobuhiro Morone, et al.
International Journal of Experimental Pathology|September 1, 2010
STAT3 modulates the DNA damage response pathwaySeán P Barry, Paul A Townsend, Richard A Knight, et al.
Biochemical and Biophysical Research Communications|October 28, 2010
p73 regulates maintenance of neural stem cellMassimiliano Agostini, Paola Tucci, Hailan Chen, et al.
Mini Reviews in Medicinal Chemistry|May 2, 2015
Perspective on multi-target antiplatelet therapies: high content phenotypic screening as an unbiased source of novel polypharmacological strategiesVivien Landré, Ivano Amelio, Nick A Barlev, et al.
The Journal of Biological Chemistry|April 2, 2008
ERK and the F-box protein betaTRCP target STAT1 for degradationSurinder M Soond, Paul A Townsend, Sean P Barry, et al.
Pageof 11